Portfolio company
Biomolex
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops digital autoradiography and molecular imaging systems for researchers performing genomic and proteomic analysis in drug discovery and precision medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Romix Bio
This company develops a molecular scan platform using cell-free RNA liquid biopsy and artificial intelligence for disease profiling and drug development for biotechnology customers.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Genomic Vision
This company develops molecular combing technology and DNA analysis tools for researchers and clinicians in diagnostic and drug discovery sectors.
MILabs
This company develops multimodal molecular imaging systems for researchers in the pharmaceutical, biomedical, and academic sectors to study diseases and develop new therapies.
Xeomics
This company develops bioinformatics software and precision medicine platforms for doctors, pharmaceutical researchers, and national healthcare systems.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
